| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.640 | 40.709 | 46.366 | 45.258 | 39.306 | 47.148 | 44.339 | 32.986 | 70.758 | 78.807 |
| Total Income - EUR | 40.290 | 42.195 | 47.604 | 45.258 | 39.306 | 47.647 | 44.603 | 32.996 | 70.816 | 78.880 |
| Total Expenses - EUR | 19.807 | 28.740 | 32.288 | 36.388 | 34.296 | 39.676 | 33.298 | 32.530 | 41.688 | 67.784 |
| Gross Profit/Loss - EUR | 20.482 | 13.455 | 15.316 | 8.870 | 5.010 | 7.972 | 11.304 | 465 | 29.127 | 11.096 |
| Net Profit/Loss - EUR | 19.280 | 13.047 | 14.027 | 8.417 | 4.617 | 7.501 | 10.867 | 140 | 28.419 | 8.804 |
| Employees | 2 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 2 | 3 |
Check the financial reports for the company - Sanroplus Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 817 | 14.721 | 11.149 | 7.682 | 4.335 | 1.243 | 0 | 0 | 0 | 0 |
| Current Assets | 55.218 | 54.773 | 56.522 | 64.968 | 70.882 | 80.197 | 29.233 | 18.062 | 40.372 | 37.980 |
| Inventories | 42 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 27.881 | 50.324 | 46.150 | 45.284 | 46.159 | 46.177 | 16.431 | 0 | 14.665 | 670 |
| Cash | 27.295 | 4.429 | 10.373 | 19.683 | 24.723 | 34.020 | 12.802 | 18.062 | 25.707 | 37.310 |
| Shareholders Funds | 51.318 | 51.595 | 53.804 | 61.233 | 64.664 | 70.940 | 23.922 | 10.320 | 38.428 | 18.896 |
| Social Capital | 11.294 | 11.178 | 10.989 | 10.788 | 10.579 | 10.378 | 10.148 | 10.179 | 10.149 | 10.092 |
| Debts | 4.716 | 17.899 | 13.868 | 11.417 | 10.552 | 10.501 | 5.312 | 7.742 | 1.944 | 19.084 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Sanroplus Medica Srl